TY - JOUR AU - Yusuf, S. AU - Reddy, S. AU - Ounpuu, S. AU - Anand, S. PY - 2001 DA - 2001// TI - Global burden of cardiovascular diseases, part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization JO - Circulation VL - 104 UR - https://doi.org/10.1161/hc4601.099487 DO - 10.1161/hc4601.099487 ID - Yusuf2001 ER - TY - JOUR AU - Popma, J. J. AU - Ohman, E. M. AU - Weitz, J. AU - Lincoff, A. M. AU - Hamrrington, R. A. AU - Berger, P. PY - 2001 DA - 2001// TI - Antiplatelet therapy in patients undergoing percutaneous coronary inter-vention JO - Chest VL - 119 UR - https://doi.org/10.1378/chest.119.1_suppl.321S DO - 10.1378/chest.119.1_suppl.321S ID - Popma2001 ER - TY - JOUR AU - Smith, S. C. AU - Dove, J. T. AU - Jacobs, A. K. AU - Kennedy, J. W. AU - Kereiakes, D. AU - Kern, M. J. PY - 2001 DA - 2001// TI - ACC/AHAguidelines for percutaneous coronary intervention: a report of theAmerican College of Cardiology/American Heart Association TaskForce on Practice Guidelines (Committee to Revise the 1993Guidelines for Percutaneous Transluminal Coronary Angioplasty) JO - J Am Coll Cardiol VL - 37 UR - https://doi.org/10.1016/S0735-1097(01)01344-4 DO - 10.1016/S0735-1097(01)01344-4 ID - Smith2001 ER - TY - JOUR AU - Steinbuhl, S. R. AU - Talley, J. D. AU - Braden, G. A. AU - Tchena, J. E. AU - Casterella, P. J. AU - Moliterno, D. J. PY - 2001 DA - 2001// TI - Point-of-care measuredplatelet inhibition correlates with a reduced risk of an adverse cardiacevent after percutaneous coronary intervention: results of the GOLD (AU-assessing Ultegra) multicenter study JO - Circulation VL - 103 UR - https://doi.org/10.1161/01.CIR.103.21.2572 DO - 10.1161/01.CIR.103.21.2572 ID - Steinbuhl2001 ER - TY - JOUR AU - Kandzari, D. E. AU - Hasselblad, V. AU - Tcheng, J. E. AU - Stone, G. W. AU - Califf, R. M. AU - Kastrati, A. PY - 2004 DA - 2004// TI - Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials JO - Am Heart J VL - 147 UR - https://doi.org/10.1016/j.ahj.2003.08.011 DO - 10.1016/j.ahj.2003.08.011 ID - Kandzari2004 ER - TY - JOUR AU - Stone, G. W. AU - Grines, C. L. AU - Cox, D. A. AU - Garcia, E. AU - Tcheng, J. E. AU - Griffin, J. J. PY - 2002 DA - 2002// TI - Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa013404 DO - 10.1056/NEJMoa013404 ID - Stone2002 ER - TY - JOUR AU - Montalescot, G. AU - Barragan, P. AU - Wittenberg, O. AU - Ecollan, P. AU - Elhadad, S. AU - Villain, P. PY - 2001 DA - 2001// TI - Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200106213442503 DO - 10.1056/NEJM200106213442503 ID - Montalescot2001 ER - TY - JOUR AU - Kereiakes, D. J. AU - Berkowitz, S. D. AU - Lincoff, A. M. AU - Tcheng, J. E. AU - Wolski, K. AU - Achenbach, R. PY - 2000 DA - 2000// TI - Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade JO - Am Heart J VL - 140 UR - https://doi.org/10.1067/mhj.2000.106615 DO - 10.1067/mhj.2000.106615 ID - Kereiakes2000 ER - TY - JOUR AU - Merlini, P. A. AU - Rossi, M. AU - Menozzi, A. AU - Buratti, S. AU - Brennan, D. M. AU - Moliterno, D. J. PY - 2004 DA - 2004// TI - Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting JO - Circulation VL - 109 UR - https://doi.org/10.1161/01.CIR.0000127867.41621.85 DO - 10.1161/01.CIR.0000127867.41621.85 ID - Merlini2004 ER - TY - STD TI - Nikolsky E, Sadeghi HM, Effron MB, Mehran R, Lansky AJ, NA Y, et al. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol. 2005;96:474–81. ID - ref10 ER - TY - JOUR AU - Tamhane, U. U. AU - Gurm, H. S. PY - 2008 DA - 2008// TI - The chimeric monoclonal antibody abciximab: a systematic review of its safety in contemporary practice JO - Expert Opin Drug Saf VL - 7 UR - https://doi.org/10.1517/14740330802500353 DO - 10.1517/14740330802500353 ID - Tamhane2008 ER - TY - JOUR AU - Araújo, G. P. AU - Ferreira, J. AU - Aguiar, C. AU - Seabra-Gomes, R. PY - 2005 DA - 2005// TI - TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS JO - Eur Heart J VL - 26 UR - https://doi.org/10.1093/eurheartj/ehi187 DO - 10.1093/eurheartj/ehi187 ID - Araújo2005 ER - TY - JOUR AU - Yusuf, S. AU - Mehta, S. R. AU - Chrolavicius, S. AU - Afzal, R. AU - Pogue, J. AU - Granger, C. B. PY - 2006 DA - 2006// TI - Comparison of fondaparinux and enoxaparin in acute coronary syndromes JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMoa055443 DO - 10.1056/NEJMoa055443 ID - Yusuf2006 ER - TY - JOUR AU - Yusuf, S. AU - Mehta, S. R. AU - Chrolavicius, S. AU - Pogue, J. AU - Granger, C. B. AU - Budaj, A. PY - 2006 DA - 2006// TI - Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.13.joc60038 DO - 10.1001/jama.295.13.joc60038 ID - Yusuf2006 ER - TY - JOUR AU - Petersen, J. L. AU - Mahaffey, K. W. AU - Hasselblad, V. AU - Antman, E. M. AU - Cohen, M. AU - Goodman, S. G. PY - 2004 DA - 2004// TI - Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview JO - JAMA VL - 292 UR - https://doi.org/10.1001/jama.292.1.89 DO - 10.1001/jama.292.1.89 ID - Petersen2004 ER - TY - JOUR AU - Rao, A. K. AU - Pratt, C. AU - Berke, A. AU - Jaffe, A. AU - Ockene, I. AU - Schreiber, T. L. PY - 1988 DA - 1988// TI - Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase JO - J Am Coll Cardiol VL - 11 UR - https://doi.org/10.1016/0735-1097(88)90158-1 DO - 10.1016/0735-1097(88)90158-1 ID - Rao1988 ER - TY - JOUR AU - Braunwald, E. AU - Antman, E. M. AU - Beasley, J. W. AU - Califf, R. M. AU - Cheitlin, M. D. AU - Hochman, J. S. PY - 2002 DA - 2002// TI - ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary articleA report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina) JO - J Am Coll Cardiol VL - 40 UR - https://doi.org/10.1016/S0735-1097(02)02336-7 DO - 10.1016/S0735-1097(02)02336-7 ID - Braunwald2002 ER - TY - JOUR AU - Boersma, E. AU - Harrington, R. A. AU - Moliterno, D. J. AU - White, H. AU - Théroux, P. AU - Werf, F. PY - 2002 DA - 2002// TI - Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)07442-1 DO - 10.1016/S0140-6736(02)07442-1 ID - Boersma2002 ER - TY - JOUR AU - Rao, S. V. AU - Jollis, J. G. AU - Harrington, R. A. AU - Granger, C. B. AU - Newby, L. K. AU - Armstrong, P. W. PY - 2004 DA - 2004// TI - Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JO - JAMA VL - 292 UR - https://doi.org/10.1001/jama.292.13.1555 DO - 10.1001/jama.292.13.1555 ID - Rao2004 ER - TY - JOUR AU - Wang, T. Y. AU - Xiao, L. AU - Alexander, K. P. AU - Rao, S. V. AU - Kosiborod, M. N. AU - Rumsfeld, J. S. PY - 2008 DA - 2008// TI - Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding JO - Circulation VL - 118 UR - https://doi.org/10.1161/CIRCULATIONAHA.108.787143 DO - 10.1161/CIRCULATIONAHA.108.787143 ID - Wang2008 ER - TY - JOUR AU - Zallen, G. AU - Moore, E. E. AU - Ciesla, D. J. AU - Brown, M. AU - Biffl, W. L. AU - Silliman, C. C. PY - 2000 DA - 2000// TI - Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2 JO - Shock VL - 13 UR - https://doi.org/10.1097/00024382-200013010-00006 DO - 10.1097/00024382-200013010-00006 ID - Zallen2000 ER - TY - JOUR AU - Fransen, E. AU - Maessen, J. AU - Dentener, M. AU - Senden, N. AU - Buurman, W. PY - 1999 DA - 1999// TI - Impact of blood transfusions on infl ammatory mediator release in patients undergoing cardiac surgery JO - Chest VL - 116 UR - https://doi.org/10.1378/chest.116.5.1233 DO - 10.1378/chest.116.5.1233 ID - Fransen1999 ER - TY - JOUR AU - Kahn, R. C. AU - Zaroulis, C. AU - Goetz, W. AU - Howland, W. S. PY - 1986 DA - 1986// TI - Hemodynamic oxygen transport and 2,3-diphosphoglycerate changes after transfusion of patients in acute respiratory failure JO - Intensive Care Med VL - 12 UR - https://doi.org/10.1007/BF00315364 DO - 10.1007/BF00315364 ID - Kahn1986 ER - TY - JOUR AU - Steg, P. G. AU - Jolly, S. S. AU - Mehta, S. R. AU - Afzal, R. AU - Xavier, D. AU - Rupprecht, H. J. PY - 2010 DA - 2010// TI - Low-dose vs. standard dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: The FUTURA/OASIS-8 randomized trial JO - JAMA VL - 304 UR - https://doi.org/10.1001/jama.2010.1320 DO - 10.1001/jama.2010.1320 ID - Steg2010 ER -